Thomas Anderson's most recent trade in Zevra Therapeutics Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Thomas D. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Highwoods Properties, Inc. | Thomas P. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 3,786 | 16,149 (0%) | 0% | 0 | Common Stock | |
| Zevra Therapeutics Inc | Thomas Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 58,800 | 58,800 | - | - | Stock Option (right to buy) | |
| Highwoods Properties, Inc. | Thomas P. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 3,211 | 12,363 (0%) | 0% | 0 | Common Stock | |
| Highwoods Properties, Inc. | Thomas P. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,215 | 7,067 (0%) | 0% | 0 | Common Stock |